BRAF Fusions Define a Distinct Molecular Subset of Melanomas with Potential Sensitivity to MEK Inhibition

PURPOSE: Recurrent “driver” mutations at specific loci in BRAF, NRAS, KIT, GNAQ, and GNA11 define clinically-relevant molecular subsets of melanoma, but >30% are “pan-negative” for these recurrent mutations. We sought to identify additional potential drivers in “pan-negative” melanoma. EXPERIMENT...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hutchinson, Katherine E., Lipson, Doron, Stephens, Philip J., Otto, Geoff, Lehmann, Brian D., Lyle, Pamela L., Vnencak-Jones, Cindy L., Ross, Jeffrey S., Pietenpol, Jennifer A., Sosman, Jeffrey A., Puzanov, Igor, Miller, Vincent A., Pao, William
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3880773/
https://ncbi.nlm.nih.gov/pubmed/24345920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-1746
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky